Does PRALSETINIB Cause Haemoglobin decreased? 35 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Haemoglobin decreased have been filed in association with PRALSETINIB (Gavreto). This represents 2.5% of all adverse event reports for PRALSETINIB.
35
Reports of Haemoglobin decreased with PRALSETINIB
2.5%
of all PRALSETINIB reports
3
Deaths
20
Hospitalizations
How Dangerous Is Haemoglobin decreased From PRALSETINIB?
Of the 35 reports, 3 (8.6%) resulted in death, 20 (57.1%) required hospitalization, and 2 (5.7%) were considered life-threatening.
Is Haemoglobin decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PRALSETINIB. However, 35 reports have been filed with the FAERS database.
What Other Side Effects Does PRALSETINIB Cause?
Death (126)
Fatigue (104)
Asthenia (96)
Off label use (92)
Hypertension (89)
Disease progression (85)
Anaemia (80)
Diarrhoea (79)
Pyrexia (75)
White blood cell count decreased (74)
What Other Drugs Cause Haemoglobin decreased?
LENALIDOMIDE (4,031)
RUXOLITINIB (3,297)
ECULIZUMAB (3,028)
ADALIMUMAB (2,459)
CLOZAPINE (2,396)
RITUXIMAB (1,803)
APIXABAN (1,779)
NIRAPARIB (1,759)
METHOTREXATE (1,754)
RIBAVIRIN (1,753)
Which PRALSETINIB Alternatives Have Lower Haemoglobin decreased Risk?
PRALSETINIB vs PRAMIPEXOLE
PRALSETINIB vs PRAMIPEXOLE\PRAMIPEXOLE
PRALSETINIB vs PRAMLINTIDE
PRALSETINIB vs PRASTERONE
PRALSETINIB vs PRASUGREL